Health Perception Practices Relations and Social Inequalities in the General Population During the Covid-19 Crisis
-
- STATUS
- Recruiting
-
- participants needed
- 110000
-
- sponsor
- Institut National de la Santé Et de la Recherche Médicale, France
Summary
This study aims to quantify and follow the cumulative incidence of SARS-CoV-2 infection in the French population using serological tests and to assess the determinants of infection from Constances, E3N-E4N, ELFE-Epipage 2 and NutriNet-Sant cohorts.
Description
The primary objective is to assess the cumulative incidence of infection in the general population using dried blood spot sampling.
The secondary objectives are:
- To identify factors associated with a positive SARS-CoV-2 infection (positive serology) and to characterize the durability of the serological response to SARS-CoV-2
- To identify associations of symptoms predictive of a SARS-CoV-2 infection
- To estimate the health care use assoicated with a SARS-CoV-2 infection
- To estimate the fraction of sub-clinical infections or infections not captured by the healthcare system;
- To study the acceptability of a mass anti-SARS-CoV-2 serological testing and the impact of its result, linked with social inequalities in health;
- To estimate the individual and collective impact of containment and other preventive measures on the risk of SARS-CoV-2 infection;
- To study the impact of social and territorial inequalities on seroprevalence levels.
Details
Condition | SARS-CoV 2 |
---|---|
Age | 100 years and younger |
Treatment | Non applicable |
Clinical Study Identifier | NCT04392388 |
Sponsor | Institut National de la Santé Et de la Recherche Médicale, France |
Last Modified on | 19 February 2024 |
How to participate?
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
Primary Contact
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.
Learn moreIf you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Learn moreComplete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.
Learn moreSimilar trials to consider
Browse trials for
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer
Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!
No annotations made yet
Add a private note
- Select a piece of text from the left.
- Add notes visible only to you.
- Send it to people through a passcode protected link.
Study Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.